AL001

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)NCT03987295ALECPhase 2Completed2024-06-05Actual
A Phase 2 Study to Evaluate AL001 in C9orf72-Associated ALSNCT05053035ALECPhase 2Terminated2022-10-28Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.